XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Stock Options, Activity (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Weighted average exercise price, beginning of period (in dollars per share) $ 3.24
Grants in period, weighted average exercise price (in dollars per share) 7.28
Exercises in period, weighted average exercise price (in dollars per share) 1.88
Forfeitures in period, weighted average exercise price (in dollars per share) 6.51
Expirations in period, weighted average exercise price (in dollars per share) 0
Weighted average exercise price, end of period (in dollars per share) 3.83
Exercisable options, weighted average exercise price (in dollars per share) $ 2.99
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Number of options, beginning of period (in shares) | shares 767,678
Number of grants in period, net of forfeitures (in shares) | shares 120,237
Number of forfeitures in period (in shares) | shares (17,388)
Number of expirations in period (in shares) | shares 0
Number of options, end of period (in shares) | shares 836,308
Number of exercisable options (in shares) | shares 667,523
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 2 years 2 months 8 days
Exercisable options, weighted average remaining contractual term 1 year 6 months 21 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $ $ 1,767
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ $ 1,766
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares 34,219
Director  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Expirations in period, weighted average exercise price (in dollars per share) $ 0
Minimum  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Weighted average exercise price, beginning of period (in dollars per share) 1.70
Grants in period, weighted average exercise price (in dollars per share) 5.34
Exercises in period, weighted average exercise price (in dollars per share) 1.70
Forfeitures in period, weighted average exercise price (in dollars per share) 3.89
Weighted average exercise price, end of period (in dollars per share) 1.70
Exercisable options, weighted average exercise price (in dollars per share) 1.70
Maximum  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Weighted average exercise price, beginning of period (in dollars per share) 8.41
Grants in period, weighted average exercise price (in dollars per share) 7.36
Exercises in period, weighted average exercise price (in dollars per share) 2.92
Forfeitures in period, weighted average exercise price (in dollars per share) 7.36
Weighted average exercise price, end of period (in dollars per share) 8.41
Exercisable options, weighted average exercise price (in dollars per share) $ 7.14
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Exercisable options, weighted average remaining contractual term 10 years
Equity Option  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]  
Number of nonvested shares, beginning of period (in shares) | shares 140,586
Granted, nonvested, number of shares (in shares) | shares 120,237
Vested, number of shares (in shares) | shares (74,651)
Nonvested options forfeited, number of shares (in shares) | shares (17,388)
Number of nonvested shares, end of period (in shares) | shares 168,784
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) $ 4.12
Granted, nonvested, weighted average grant date fair value (in dollars per share) 3.98
Vested, weighted average grant date fair value (in dollars per share) 3.76
Nonvested options forfeited, weighted average grant date fair value (in dollars per share) 3.87
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 3.97